<DOC>
	<DOCNO>NCT02634671</DOCNO>
	<brief_summary>Background : The present study aim identify mechanism underlie deficit facial emotion recognition report schizophrenia 22q11.2 deletion syndrome , thus , reveal distinction two disorder . Indeed , despite clinical overlap two syndrome , symptom appear specific one . In particular , disturbance visual function specifically observe 22q11.2DS . Hence , difficulties facial emotion recognition schizophrenia 22q11.DS likely account different cognitive impairment . Investigating mechanisms disturb would allow specialized support patient . Our main hypothesis deficit facial emotion recognition relate visual impairment 22q11.2DS schizophrenia . This hypothesis test two group patient ( 22q11.2DS schizophrenic patient ) control group ( healthy subject ) use experimental paradigm base electroencephalography ( EEG ) . A second aim study determine whether severity two disorder ' symptom correlate cerebral response facial expression . To answer question , set clinical neuropsychological test conduct patient .</brief_summary>
	<brief_title>Perception Facial Emotions Schizophrenia 22q11 Deletion Syndrome</brief_title>
	<detailed_description>Methods : This study conduct use visual steady-state visual evoke potential ( SSVEPs ) . Visual SSVEPs periodic neural electrophysiological activity arise response fast periodic visual stimulation ( FPVS ) . They record response periodic presentation face , accord oddball paradigm . While picture face appear 6 Hz rate , 1 5 display emotion , correspond 1.2 Hz oddball frequency . Different emotion test ( happiness , sadness , anger , fear disgust ) , display different intensity ( 20 % , 60 % , 100 % ) . SSVEPs 6 Hz reflect general visual mechanism ( response mixture low-level ( i.e. , contrast coding ) high-level ( i.e. , face detection ) process ) . Importantly , SSVEPs 1.2 Hz index visual mechanism specifically involved facial expression perception sensitivity emotion intensity . Both measure help determine underlying brain topography . Alongside , clinical neuropsychological test conduct . While clinical test evaluate severity symptom , neuropsychological test assess different feature attention , memory , verbal visuo-spatial ability . The patient ' score link cerebral activity response facial expression . Outcomes : To good understand impairment facial emotion recognition schizophrenia 22q11.2DS improve care .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>22q11 Deletion Syndrome</mesh_term>
	<criteria>Aged 1550 year old No psychiatric condition comorbidity Agreement parent participant underage Patients schizophrenia : diagnosis assess DSM5 criterion Patients 22q11.2 DS : diagnosis assess genetic test ( CGH array FISH ) No mental delay ( IQ &gt; 70 accord fNART ) No modification psychotropic treatment month inclusion Involvement current program social cognition remediation Pregnancy Substance use disorder ( criterion DSM5 ) , except caffeine tobacco Neurologic disorder ( vascular , infectious neurodegenerative ) Uncorrected visual deficit Guardianship Medical drug cerebral psychological effect ( e.g , corticosteroid ) Resistance antipsychotic Electroconvulsive therapy previous two month</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>Facial emotion</keyword>
</DOC>